Pyrroloquinoline quinone prevents testosterone deficiency-induced osteoporosis by stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorption.
about
Pyrroloquinoline quinone prevents testosterone deficiency-induced osteoporosis by stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorption.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@en
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@nl
type
label
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@en
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@nl
prefLabel
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@en
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@nl
P2093
P2860
P1476
Pyrroloquinoline quinone preve ...... osteoclastic bone resorption.
@en
P2093
P2860
P304
P407
P577
2017-03-15T00:00:00Z